Amylyx Pharmaceuticals, Inc.
corporate_fare Company Profile
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for AMLX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Amylyx Reports Significantly Reduced Net Loss, Extended Cash Runway, and Pivotal Phase 3 Trial Completion
- Amylyx Pharmaceuticals Expands Pipeline with New GLP-1 Receptor Antagonist Candidate AMX0318
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$144.74M
Diluted EPS
-$1.53
Op. Cash Flow
-$123.34M
Free Cash Flow
-$123.48M
Gross Profit
$0
Operating Income
-$153.29M
Cash & Equivalents
$226.65M
Debt / Equity
0.00×
Shares Outstanding
109.88M sh
Source: 10-K · filed 2026-03-03 · accession 0001193125-26-086645
show_chartPrice Chart
Loading chart...